Imperva (NASDAQ:IMPV) was upgraded by equities researchers at ValuEngine from a “sell” rating to a “hold” rating in a research report issued to clients and investors on Thursday, February 15th.
IMPV has been the topic of a number of other research reports. Piper Jaffray Companies upgraded Imperva from a “neutral” rating to an “overweight” rating and set a $52.00 target price on the stock in a research note on Friday, February 9th. JPMorgan Chase & Co. lowered Imperva from a “neutral” rating to an “underweight” rating and set a $45.00 target price on the stock. in a research note on Tuesday, December 12th. Zacks Investment Research lowered Imperva from a “buy” rating to a “hold” rating in a research note on Wednesday, January 10th. Imperial Capital increased their target price on Imperva from $50.00 to $55.00 and gave the stock an “outperform” rating in a research note on Friday, February 9th. Finally, KeyCorp restated a “hold” rating on shares of Imperva in a research note on Tuesday, October 24th. Three investment analysts have rated the stock with a sell rating, four have given a hold rating, eleven have given a buy rating and one has assigned a strong buy rating to the company. The company currently has an average rating of “Buy” and a consensus price target of $53.14.
Imperva (NASDAQ:IMPV) traded down $0.35 during mid-day trading on Thursday, reaching $46.50. The company’s stock had a trading volume of 689,318 shares, compared to its average volume of 423,184. Imperva has a twelve month low of $37.17 and a twelve month high of $52.40. The stock has a market capitalization of $1,619.40, a price-to-earnings ratio of 68.38 and a beta of 1.65.
Imperva (NASDAQ:IMPV) last released its earnings results on Thursday, February 8th. The software maker reported $0.40 earnings per share for the quarter, topping analysts’ consensus estimates of $0.27 by $0.13. Imperva had a negative return on equity of 3.28% and a net margin of 7.11%. The business had revenue of $91.10 million for the quarter, compared to analyst estimates of $91.11 million. During the same quarter last year, the firm posted $0.32 earnings per share. The business’s revenue was up 16.2% compared to the same quarter last year. equities analysts forecast that Imperva will post -0.17 earnings per share for the current year.
In related news, Director Anthony J. Bettencourt sold 66,037 shares of the firm’s stock in a transaction dated Tuesday, February 20th. The stock was sold at an average price of $46.98, for a total transaction of $3,102,418.26. Following the sale, the director now owns 66,037 shares of the company’s stock, valued at $3,102,418.26. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, CRO Michael D. Mooney sold 24,454 shares of the firm’s stock in a transaction dated Tuesday, February 20th. The shares were sold at an average price of $47.18, for a total value of $1,153,739.72. Following the sale, the executive now directly owns 24,454 shares in the company, valued at approximately $1,153,739.72. The disclosure for this sale can be found here. 1.90% of the stock is owned by company insiders.
Hedge funds have recently modified their holdings of the stock. New York State Common Retirement Fund boosted its position in Imperva by 5.3% during the second quarter. New York State Common Retirement Fund now owns 35,800 shares of the software maker’s stock valued at $1,713,000 after purchasing an additional 1,793 shares in the last quarter. Wells Fargo & Company MN boosted its holdings in Imperva by 11.9% in the third quarter. Wells Fargo & Company MN now owns 213,953 shares of the software maker’s stock worth $9,285,000 after acquiring an additional 22,741 shares in the last quarter. Prudential Financial Inc. boosted its holdings in Imperva by 80.7% in the third quarter. Prudential Financial Inc. now owns 54,174 shares of the software maker’s stock worth $2,351,000 after acquiring an additional 24,190 shares in the last quarter. American Century Companies Inc. acquired a new stake in Imperva in the third quarter worth about $6,832,000. Finally, Bank of New York Mellon Corp boosted its holdings in Imperva by 10.8% in the third quarter. Bank of New York Mellon Corp now owns 150,752 shares of the software maker’s stock worth $6,542,000 after acquiring an additional 14,727 shares in the last quarter.
ILLEGAL ACTIVITY WARNING: “Imperva (IMPV) Upgraded to Hold by ValuEngine” was reported by The Ledger Gazette and is owned by of The Ledger Gazette. If you are accessing this report on another publication, it was copied illegally and republished in violation of U.S. & international copyright and trademark law. The original version of this report can be read at https://ledgergazette.com/2018/03/13/valuengine-upgrades-imperva-impv-to-hold.html.
Imperva, Inc provides cyber-security solutions that protect business-critical data and applications whether in the cloud or on premises. The Company is engaged in the development, marketing, sales, service and support of cyber-security solutions. The Company’s products include its Imperva SecureSphere Paltform, Imperva CounterBreach and Imperva Camouflage for enterprise data centers, and Imperva Incapsula offering for cloud-based security services.
To view ValuEngine’s full report, visit ValuEngine’s official website.
Receive News & Ratings for Imperva Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Imperva and related companies with MarketBeat.com's FREE daily email newsletter.